Table 1 Clinical characteristics of cohort-1 depending on the RBM15 expression levels.
Factor | RBM15-low | RBM15-high | n | χ2 | p |
|---|---|---|---|---|---|
All case | 26 | 34 | 60 | ||
Age | 0.331 | 0.565 | |||
≤60 | 19 | 27 | 46 | ||
>60 | 7 | 7 | 14 | ||
AJCC stage | 0.087 | 0.768 | |||
Stage I–II | 12 | 17 | 29 | ||
Stage III–IV | 14 | 17 | 31 | ||
Tumor number | 2.527 | 0.112 | |||
Single | 19 | 18 | 37 | ||
Multiple | 7 | 16 | 23 | ||
Tumor size | 0.432 | 0.555 | |||
≤5 cm | 5 | 9 | 14 | ||
>5 cm | 21 | 25 | 46 | ||
Tumor encapsulation | 2.986 | 0.117 | |||
Intact | 11 | 22 | 33 | ||
Broken | 15 | 12 | 27 | ||
Microvascular infiltration | 0.160 | 0.689 | |||
Yes | 5 | 8 | 13 | ||
No | 21 | 26 | 47 | ||
HbsAg | 1.750 | 0.307 | |||
Negative | 3 | 1 | 4 | ||
Positive | 23 | 33 | 56 | ||
Cirrhosis | 0.271 | 0.602 | |||
Yes | 20 | 28 | 48 | ||
No | 6 | 6 | 12 | ||
AFP | 4.103 | 0.043 | |||
≤400 μg/L | 19 | 16 | 35 | ||
>400 μg/L | 7 | 18 | 25 |
